Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Schering Says Smaller Is Better: Flexibility Aids Turnaround Process

Executive Summary

Schering-Plough's smaller size will be an advantage as the company implements its turnaround plan, CEO Fred Hassan told investors during a business briefing in New York Nov. 18

You may also be interested in...

Schering Stabilizes Market Share Losses With Revamped Sales Effort

Schering-Plough's efficacy-based sales and marketing messages have helped stabilize share losses within the company's primary care business, Global Pharmaceutical President Carrie Cox said

Bayer Layoffs, Spin-Offs Will Leave “Mid-Sized” European Company

Bayer is comfortable being a mid-sized European pharmaceutical company

Merck Won’t Go Hollywood: In-House R&D Still Focus As Outside Deals Expand

Merck is on a pace to sign 50 outside R&D alliances during 2003

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts